CNIPA.AI
Back to Search
Dossier

USE OF EBSELEN OR ONE OF THE DERIVATIVES THEREOF TO TREAT MITOCHONDRIAL PATHOLOGIES OR DYSFUNCTIONS

InventionPending
15Claims · 1 independent
§ Ⅰ

Dossier Overview

Applicant

ASSOCIATION FRANCAISE CONTRE LES MYOPATHIES; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE; UNIVERSITE D'ANGERS; UNIVERSITE DE BORDEAUX; UNIVERSITE PARIS-SACLAY; UNIVERSITE COTE D'AZUR; CENTRE HOSPITALIER UNIVERSITAIRE D'ANGERS

Inventor

Déborah TRIBOUILLARD-TANVIER; Stéphane AZOULAY; Vincent PROCACCIO; Carole SELLEM

IPC Classification

A61K 31/41A61K 9/C12N 3/

CPC Classification

A61K31/41A61K9/53C12N3/

The invention relates to the use of ebselen or one of the derivatives thereof for treating pathologies or mitochondrial malfunctions in particular associated with complex I deficiencies.

Original (Chinese)

The invention relates to the use of ebselen or one of the derivatives thereof for treating pathologies or mitochondrial malfunctions in particular associated with complex I deficiencies.

External Resources